Jen‐Tsun Lin

825 total citations
34 papers, 669 citations indexed

About

Jen‐Tsun Lin is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Jen‐Tsun Lin has authored 34 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Surgery and 6 papers in Oncology. Recurrent topics in Jen‐Tsun Lin's work include MicroRNA in disease regulation (3 papers), Natural product bioactivities and synthesis (3 papers) and Phytochemical compounds biological activities (3 papers). Jen‐Tsun Lin is often cited by papers focused on MicroRNA in disease regulation (3 papers), Natural product bioactivities and synthesis (3 papers) and Phytochemical compounds biological activities (3 papers). Jen‐Tsun Lin collaborates with scholars based in Taiwan, India and Canada. Jen‐Tsun Lin's co-authors include Mu‐Kuan Chen, Ming‐Ju Hsieh, Yi‐Ching Chuang, Yu‐Sheng Lo, Po‐Min Chen, Yi‐Ting Hsi, Chia‐Chieh Lin, Su‐Yu Chien, Liu H and Wei‐Shu Wang and has published in prestigious journals such as Cancer, International Journal of Molecular Sciences and The Journal of Urology.

In The Last Decade

Jen‐Tsun Lin

32 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jen‐Tsun Lin Taiwan 16 306 126 96 85 82 34 669
Nobutaka Fujisawa Japan 14 276 0.9× 141 1.1× 136 1.4× 44 0.5× 42 0.5× 25 726
Xiaoying Zhao China 13 245 0.8× 86 0.7× 70 0.7× 37 0.4× 42 0.5× 35 501
Jia Fei China 17 429 1.4× 99 0.8× 194 2.0× 123 1.4× 30 0.4× 55 884
Yuichi Nakamura Japan 18 393 1.3× 149 1.2× 75 0.8× 77 0.9× 111 1.4× 62 1.0k
Guoying Zhang China 14 307 1.0× 106 0.8× 85 0.9× 29 0.3× 86 1.0× 31 846
Maokaı̈ Gong United States 13 349 1.1× 262 2.1× 53 0.6× 184 2.2× 55 0.7× 15 915
Youqiu Xue China 13 331 1.1× 173 1.4× 57 0.6× 51 0.6× 61 0.7× 18 734
Sagar Sardesai United States 13 175 0.6× 174 1.4× 90 0.9× 35 0.4× 66 0.8× 47 603
Madhu M. Ouseph United States 13 266 0.9× 179 1.4× 95 1.0× 33 0.4× 69 0.8× 37 719
Basharut A. Syed United Kingdom 15 250 0.8× 77 0.6× 50 0.5× 73 0.9× 94 1.1× 24 678

Countries citing papers authored by Jen‐Tsun Lin

Since Specialization
Citations

This map shows the geographic impact of Jen‐Tsun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jen‐Tsun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jen‐Tsun Lin more than expected).

Fields of papers citing papers by Jen‐Tsun Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jen‐Tsun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jen‐Tsun Lin. The network helps show where Jen‐Tsun Lin may publish in the future.

Co-authorship network of co-authors of Jen‐Tsun Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jen‐Tsun Lin. A scholar is included among the top collaborators of Jen‐Tsun Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jen‐Tsun Lin. Jen‐Tsun Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsieh, Ming‐Ju, Jen‐Tsun Lin, Yi‐Ching Chuang, et al.. (2024). Raddeanin A augments the cytotoxicity of natural killer cells against chronic myeloid leukaemia cells by modulating MAPK and Ras/Raf signalling pathways. Journal of Cellular and Molecular Medicine. 28(16). e70016–e70016. 2 indexed citations
2.
Hsieh, Ming‐Ju, Jen‐Tsun Lin, Yi‐Ching Chuang, et al.. (2023). Limocitrin increases cytotoxicity of KHYG‐1 cells against K562 cells by modulating MAPK pathway. Environmental Toxicology. 38(12). 2939–2951. 1 indexed citations
3.
Chuang, Yi‐Ching, Ming‐Chang Hsieh, Yu‐Sheng Lo, et al.. (2021). Pinosylvin inhibits migration and invasion of nasopharyngeal carcinoma cancer cells via regulation of epithelial‑mesenchymal transition and inhibition of MMP‑2. Oncology Reports. 46(1). 16 indexed citations
4.
Velmurugan, Bharath Kumar, Jen‐Tsun Lin, B. Mahalakshmi, et al.. (2020). Luteolin-7-O-Glucoside Inhibits Oral Cancer Cell Migration and Invasion by Regulating Matrix Metalloproteinase-2 Expression and Extracellular Signal-Regulated Kinase Pathway. Biomolecules. 10(4). 502–502. 36 indexed citations
5.
Chen, Jianming, et al.. (2020). Antimetastatic Effects of Sesamin on Human Head and Neck Squamous Cell Carcinoma through Regulation of Matrix Metalloproteinase-2. Molecules. 25(9). 2248–2248. 15 indexed citations
6.
Chen, Mu‐Kuan, Yen‐Tze Liu, Jen‐Tsun Lin, et al.. (2019). Pinosylvin reduced migration and invasion of oral cancer carcinoma by regulating matrix metalloproteinase-2 expression and extracellular signal-regulated kinase pathway. Biomedicine & Pharmacotherapy. 117. 109160–109160. 26 indexed citations
7.
Liu, Yen‐Tze, Ming‐Ju Hsieh, Jen‐Tsun Lin, et al.. (2019). Coronarin D induces human oral cancer cell apoptosis though upregulate JNK1/2 signaling pathway. Environmental Toxicology. 34(4). 513–520. 10 indexed citations
8.
Liu, Yen‐Tze, Ming‐Ju Hsieh, Jen‐Tsun Lin, et al.. (2018). Erianin induces cell apoptosis through ERK pathway in human nasopharyngeal carcinoma. Biomedicine & Pharmacotherapy. 111. 262–269. 42 indexed citations
9.
Hsieh, Ming‐Ju, Jen‐Tsun Lin, Yi‐Ching Chuang, et al.. (2018). Celastrol, a plant-derived triterpene, induces cisplatin-resistance nasopharyngeal carcinoma cancer cell apoptosis though ERK1/2 and p38 MAPK signaling pathway. Phytomedicine. 58. 152805–152805. 50 indexed citations
10.
11.
Hsieh, Ming‐Ju, Su‐Yu Chien, Jen‐Tsun Lin, Shun‐Fa Yang, & Mu‐Kuan Chen. (2016). Polyphyllin G induces apoptosis and autophagy cell death in human oral cancer cells. Phytomedicine. 23(13). 1545–1554. 44 indexed citations
12.
Lin, Jen‐Tsun, et al.. (2013). Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6. Experimental Cell Research. 319(14). 2216–2229. 67 indexed citations
13.
Lin, Jen‐Tsun, et al.. (2011). Chemotherapy with Modified Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Metastatic Head and Neck Cancer. Advances in Therapy. 29(1). 71–77. 18 indexed citations
14.
Chen, Chih‐Cheng, Jyh‐Pyng Gau, Jie‐Yu You, et al.. (2008). Prognostic significance of β‐catenin and topoisomerase IIα in de novo acute myeloid leukemia. American Journal of Hematology. 84(2). 87–92. 24 indexed citations
15.
Yeh, Kun‐Tu, et al.. (2004). Expression of c-kit protooncogene in human hepatocellular carcinoma. Cancer Letters. 217(2). 231–236. 28 indexed citations
16.
Lin, Jen‐Tsun, et al.. (2003). Prolonged Reversible Vasospasm in Cyclosporin A-Induced Encephalopathy. American Journal of Neuroradiology. 24(1). 102–104. 59 indexed citations
17.
Hsiao, Liang‐Tsai, Jen‐Tsun Lin, I‐Ting Yu, et al.. (2003). High serum hepatocyte growth factor level in patients with non‐Hodgkin's lymphoma. European Journal Of Haematology. 70(5). 282–289. 21 indexed citations
18.
Hsiao, Liang‐Tsai, Jen‐Tsun Lin, Tzeon‐Jye Chiou, et al.. (2002). Stevens–Johnson syndrome after treatment with STI571: a case report. British Journal of Haematology. 117(3). 620–622. 77 indexed citations
19.
Lin, Jen‐Tsun, et al.. (2002). Prurigo Nodularis as Initial Presentation of Metastatic Transitional Cell Carcinoma of the Bladder. The Journal of Urology. 168(2). 631–632. 7 indexed citations
20.
Chen, Po‐Min, Muh‐Hwa Yang, I‐Ting Yu, et al.. (2002). Low incidence of BCL‐6 gene alterations for diffuse large B‐cell lymphomas in Taiwan Chinese. Cancer. 94(10). 2635–2644. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026